Critical role for the NLRP3 inflammasome during acute lung injury
- PMID: 24795455
- PMCID: PMC4061751
- DOI: 10.4049/jimmunol.1400368
Critical role for the NLRP3 inflammasome during acute lung injury
Abstract
The inflammasome is a key factor in innate immunity and senses soluble pathogen and danger-associated molecular patterns as well as biological crystals (urate, cholesterol, etc.), resulting in expression of IL-1β and IL-18. Using a standard model of acute lung injury (ALI) in mice featuring airway instillation of LPS, ALI was dependent on availability of NLRP3 as well as caspase-1, which are known features of the NLRP3 inflammasome. The appearance of IL-1β, a product of NLRP3 inflammasome activation, was detected in bronchoalveolar lavage fluids (BALF) in a macrophage- and neutrophil-dependent manner. Neutrophil-derived extracellular histones appeared in the BALF during ALI and directly activated the NLRP3 inflammasome. Ab-mediated neutralization of histones significantly reduced IL-1β levels in BALF during ALI. Inflammasome activation by extracellular histones in LPS-primed macrophages required NLRP3 and caspase-1 as well as extrusion of K(+), increased intracellular Ca(2+) concentration, and generation of reactive oxygen species. NLRP3 and caspase-1 were also required for full extracellular histone presence during ALI, suggesting a positive feedback mechanism. Extracellular histone and IL-1β levels in BALF were also elevated in C5a-induced and IgG immune complex ALI models, suggesting a common inflammatory mechanism. These data indicate an interaction between extracellular histones and the NLRP3 inflammasome, resulting in ALI. Such findings suggest novel targets for treatment of ALI, for which there is currently no known efficacious drug.
Copyright © 2014 by The American Association of Immunologists, Inc.
Figures
Similar articles
-
Histones trigger sterile inflammation by activating the NLRP3 inflammasome.Eur J Immunol. 2013 Dec;43(12):3336-42. doi: 10.1002/eji.201243224. Epub 2013 Sep 6. Eur J Immunol. 2013. PMID: 23964013
-
Intranasal Application of Budesonide Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Nucleotide-Binding Oligomerization Domain-Like Receptor Family, Pyrin Domain-Containing 3 Inflammasome Activation in Mice.J Immunol Res. 2019 Feb 27;2019:7264383. doi: 10.1155/2019/7264383. eCollection 2019. J Immunol Res. 2019. PMID: 30937316 Free PMC article.
-
The NLRP3 inflammasome is required for the development of hypoxemia in LPS/mechanical ventilation acute lung injury.Am J Respir Cell Mol Biol. 2014 Feb;50(2):270-80. doi: 10.1165/rcmb.2013-0087OC. Am J Respir Cell Mol Biol. 2014. PMID: 24007300 Free PMC article.
-
Mechanism and Regulation of NLRP3 Inflammasome Activation.Trends Biochem Sci. 2016 Dec;41(12):1012-1021. doi: 10.1016/j.tibs.2016.09.002. Epub 2016 Sep 23. Trends Biochem Sci. 2016. PMID: 27669650 Free PMC article. Review.
-
The NLRP3 inflammasome: role in airway inflammation.Clin Exp Allergy. 2014 Feb;44(2):160-72. doi: 10.1111/cea.12206. Clin Exp Allergy. 2014. PMID: 24118105 Review.
Cited by
-
Tabersonine, a natural NLRP3 inhibitor, suppresses inflammasome activation in macrophages and attenuate NLRP3-driven diseases in mice.Acta Pharmacol Sin. 2023 Jun;44(6):1252-1261. doi: 10.1038/s41401-022-01040-z. Epub 2023 Jan 10. Acta Pharmacol Sin. 2023. PMID: 36627344 Free PMC article.
-
Endosomal trafficking of two-pore K+ efflux channel TWIK2 to plasmalemma mediates NLRP3 inflammasome activation and inflammatory injury.Elife. 2023 May 9;12:e83842. doi: 10.7554/eLife.83842. Elife. 2023. PMID: 37158595 Free PMC article.
-
Genetic inactivation of the phospholipase A2 activity of peroxiredoxin 6 in mice protects against LPS-induced acute lung injury.Am J Physiol Lung Cell Mol Physiol. 2019 Apr 1;316(4):L656-L668. doi: 10.1152/ajplung.00344.2018. Epub 2019 Jan 31. Am J Physiol Lung Cell Mol Physiol. 2019. PMID: 30702344 Free PMC article.
-
Dexmedetomidine alleviates blunt chest trauma and hemorrhagic shock‑resuscitation‑induced acute lung injury through inhibiting the NLRP3 inflammasome.Mol Med Rep. 2020 Sep;22(3):2507-2515. doi: 10.3892/mmr.2020.11335. Epub 2020 Jul 10. Mol Med Rep. 2020. PMID: 32705267 Free PMC article.
-
Activation of the IL-1β/KLF2/HSPH1 pathway promotes STAT3 phosphorylation in alveolar macrophages during LPS-induced acute lung injury.Biosci Rep. 2020 Mar 27;40(3):BSR20193572. doi: 10.1042/BSR20193572. Biosci Rep. 2020. PMID: 32091104 Free PMC article.
References
-
- Goss CH, Brower RG, Hudson LD, Rubenfeld GD. Incidence of acute lung injury in the United States. Crit Care Med. 2003;31:1607–1611. - PubMed
-
- Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303–1310. - PubMed
-
- Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, Fernandes-Alnemri T, Wu J, Monks BG, Fitzgerald KA, Hornung V, Latz E. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol. 2009;183:787–791. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
